Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Exchange Rate Effect (2022 - 2025)

Viking Therapeutics' Exchange Rate Effect history spans 4 years, with the latest figure at $9000.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 112.16% year-over-year to $9000.0; the TTM value through Dec 2025 reached -$8000.0, up 94.59%, while the annual FY2025 figure was -$8000.0, 94.59% up from the prior year.
  • Exchange Rate Effect for Q4 2025 was $9000.0 at Viking Therapeutics, up from -$6000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $141000.0 in Q4 2022 and bottomed at -$223000.0 in Q3 2022.
  • The 4-year median for Exchange Rate Effect is -$7500.0 (2023), against an average of -$19142.9.
  • The largest annual shift saw Exchange Rate Effect soared 200.0% in 2024 before it tumbled 500.0% in 2025.
  • A 4-year view of Exchange Rate Effect shows it stood at $141000.0 in 2022, then tumbled by 64.54% to $50000.0 in 2023, then crashed by 248.0% to -$74000.0 in 2024, then soared by 112.16% to $9000.0 in 2025.
  • Per Business Quant, the three most recent readings for VKTX's Exchange Rate Effect are $9000.0 (Q4 2025), -$6000.0 (Q3 2025), and -$12000.0 (Q2 2025).